Tzu‐Hua Chang - Concepedia

Author

Tzu‐Hua Chang

National Taiwan University Hospital

Also Known As

T.Y.A. Chang, Tzu-Hua Chang, Tzu‐Hua Chang

Publications

605

Citations

H-Index

Concepts

All Affiliations

National Taiwan University Hospital National Taiwan University Dayeh University Far Eastern Memorial Hospital

About

Tzu‐Hua Chang is an author at National Taiwan University Hospital specializing in lung cancer, tumor biology, and cancer biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	286
2	Cell Biology	3	3	286
3	Health Sciences	1	1	165
4	Cell Signaling	1	1	60
5	Stem Cells	1	1	165

Tzu‐Hua Chang

Publications

515

Citations

H-Index

Page 1

	Year	Citations
ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors Cheng-Po Huang, Meng‐Feng Tsai, Tzu‐Hua Chang, Cancer Letters OncologyMedicineReceptor Tyrosine KinaseBronchial NeoplasmCancer Biology	2012	165
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer Yinan Liu, Tzu‐Hua Chang, Meng‐Feng Tsai, Oncotarget	2015	86
Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C Tzu‐Hua Chang, Meng‐Feng Tsai, Chien‐Hung Gow, Cancer Letters Microrna-137 ExpressionMedicineMicrorna DetectionTumor SuppressorSlug Promotes	2017	61
Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer Yi‐Nan Liu, Meng‐Feng Tsai, Shang‐Gin Wu, International Journal of Cancer Higher LevelsMedicineReceptor Tyrosine KinaseBronchial NeoplasmEgfr Tki Resistance	2019	60
miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway Yinan Liu, Meng‐Feng Tsai, Shang‐Gin Wu, Molecular Therapy — Nucleic Acids	2020	44
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process Hsin‐Yi Wang, Yinan Liu, Shang‐Gin Wu, Cancer Biomarkers	2020	39
IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer Shang‐Gin Wu, Tzu‐Hua Chang, Meng‐Feng Tsai, Cancers	2019	24
LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis Yi‐Ling Chen, Yinan Liu, Yen‐Ting Lin, Journal of Biomedical Science	2023	18
miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44 Shang‐Gin Wu, Tzu‐Hua Chang, Meng‐Feng Tsai, Molecular Therapy — Nucleic Acids	2023	18

Page 1